Judge Advises Freeing Amgen, Teva From Suits Over Sensipar
A Delaware federal judge has recommended the dismissal of two antitrust class actions against pharmaceutical giants Amgen and Teva Pharmaceuticals over their agreement to pull a generic version of a calcium...To view the full article, register now.
Already a subscriber? Click here to view full article